It is time to rethink the dual antiplatelet therapy indication in revascularization surgery. Rev. Fed. Arg. Cardiol. [Internet]. 2023 Mar. 30 [cited 2026 Oct. 5];52(1):5-7. Available from: https://www.revistafac.org.ar/ojs/index.php/revistafac/article/view/446